Dr. Andrea Soergel
About Dr. Andrea Soergel
Dr. Andrea Soergel is the Associate Director of Clinical Operations at Bristol-Myers Squibb in München, Bayern, Deutschland, with over 20 years of experience in clinical research and operations.
Current Position at Bristol-Myers Squibb
Dr. Andrea Soergel serves as the Associate Director of Clinical Operations at Bristol-Myers Squibb in München, Bayern, Deutschland. She transitioned to this role in 2020 after holding a managerial position within the same company. In her current capacity, Dr. Soergel oversees clinical operations, leveraging her extensive experience and expertise in the field.
Past Experience at Bristol-Myers Squibb
From 2016 to 2020, Dr. Andrea Soergel worked at Bristol-Myers Squibb GmbH & Co. KGaA as the Manager Operations Unit for Regional Clinical Operations DACH. Her four-year tenure in this role involved overseeing clinical operations at a regional level, ensuring that clinical trials were conducted efficiently and in compliance with regulatory standards.
Previous Roles in Clinical Research Management
Dr. Andrea Soergel has held several key positions in clinical research management. From 2010 to 2016, she was a Clinical Research Manager at MSD Sharp & Dohme GmbH in Munich - Haar. Prior to that, she worked at Essex Pharma GmbH from 2008 to 2010 as a Clinical Project Leader & Clinical Research Manager. Her career in clinical research began at Servier as a CRA from 1998 to 2000 in the Munich Area.
Senior CRA at Organon GmbH
Dr. Andrea Soergel spent eight years at Organon GmbH, from 2000 to 2008. She advanced from a Clinical Research Associate (CRA) to a Senior CRA during her tenure. This period greatly contributed to her depth of knowledge and expertise in clinical research and operations, setting the foundation for her subsequent career advancements.
Educational Background in Molecular Biology and Virology
Dr. Andrea Soergel studied at Friedrich-Alexander-Universität Erlangen-Nürnberg, where she specialized in Molecular Biology and Virology. She earned her PhD after nine years of dedicated study, from 1989 to 1998. Her academic background has been instrumental in her professional journey, providing a solid scientific foundation for her work in clinical research and operations.